Made available in DSpace on 2016-01-26T12:51:54Z (GMT). No. of bitstreams: 1 elisabetemelo_tese.pdf: 1119413 bytes, checksum: 4be114b65ecba8ea4e5468dff03f2f12 (MD5) Previous issue date: 2006-08-14 / Hepatopulmonary syndrome (HPS), caused by abnormal intrapulmonary vasodilatation (IPVD), when associated with severe hypoxemia has been related to increased morbid-mortality in liver transplant candidates. The progression of hypoxemia in cirrhotic patients with IPVD is not well known. The aim of this study is to determine the probability of developing hypoxemia (Pa02 <70mmHg) in IPVD patients waiting for liver transplantation over two years. Thirty-two transplant candidates with IPVD detected by contrast-enhanced echocardiography (GI) were prospectively studied and the Pa02 of then was measured at the start and at the end of 12 and 24 months. Eleven patients without IPVD were taken as control group (GII). Paired t test showed that mean Pa02 was significantly lower at 24 months compared with basal mean at GI (78,5 ± 18,9 vs 94,05 ± 14,9; p=0,001). GI patients had significantly lower mean Pa02 at 12 months (84,6 ± 14,8 vs 95,7 ± 7,3; p=0,003) and at 24 months (78,5 ± 19,0 vs 88,7 ± 7,1; p=0,036) compared with GII patients. The Kaplan-Meier estimated ratio for the appearance of hypoxemia was approximately 10% ±5% at 12 months and 28% ± 10% at 2 years. The mean variation for Pa02 in GI patients was 4,6±13,4mmHg at 12 months and 15,5±15,5mmHg at the end of two years. There was no appearance of either hypoxemia or IPVD in GII patients. The variables: age, Child-Pugh score, smoking habit, pré-transplant Pa02 and PaC02 values did not discriminated patients who presented hypoxemia during the period of two years study. In conclusion, we demonstrate prospectively the progressive course of HPS, even on it s subclinical stage; the estimated risk for the appearance of hypoxemia in patients with IPVD was at least 30% at the end of 2 years. The identification of the early appearance of hypoxemia can lead to a better understanding of the hepatopulmonary syndrome natural history and may be helpful to optimize timing and to predict the outcomes of liver transplantation. / A síndrome hepatopulmonar (SHP) é causada por dilatação anormal da vasculatura intrapulmonar (DVP) em indivíduos com doença hepática, tendo como consequência graus variados de hipoxemia arterial. A hipoxemia grave aumenta a morbimortalidade em candidatos a transplante de fígado, e sua progressão na história natural da SHP não é bem conhecida. O objetivo deste estudo é determinar a probabilidade de desenvolvimento de hipoxemia (Pa02 <70mmHg) em pacientes com DVP em lista de espera para o transplante de fígado, em um período de dois anos. Foram estudados prospectivamente 32 pacientes com DVP (GI), detectada pela ecocardiografia com contraste e a Pa02 foi medida ao início, aos 12 e aos 24 meses do estudo. Como grupo controle (GII), foram incluídos 11 pacientes sem DVP. Os testes t de Student e exato de Fisher foram usados para comparação dos resultados. A curva de Kaplan-Meier foi empregada para verificar a probabilidade de hipoxemia nos dois grupos. A média da Pa02 aos 12 e 24 meses foi significativamente menor no GI quando comparada ao GII (84,6±14,8mmHg vs 95,7±7,3mmHg; p=0,003 e 78,5±19,0mmHg vs 88,7±7,1mmHg; p=0,036, respectivamente). No GI há evidência de que a média dos valores da Pa02 aos 24 meses é menor do que a média basal (78,5±18,9 vs 94,0±14,9; p=0,001). A razão estimada para o aparecimento da hipoxemia foi aproximadamente 10%±5% aos 12 meses e 28%±10% aos 24 meses (Curva Kaplan-Meier), para o GI. A média da variação da Pa02 no GI foi de 4,6&#61617;13,4mmHg aos 12 meses e de 15,5&#61617;15,5mmHg aos 24 meses. Nenhum paciente apresentou hipoxemia nem DVP no GII durante o período de estudo. Os parâmetros: idade, Child-Pugh, tabagismo, Pa02 e PaC02 iniciais, não identificaram os indivíduos com DVP que desenvolveram hipoxemia em dois anos de observação. Conclui-se que: Demonstramos o curso progressivo da SHP, mesmo em condições subclínicas; O risco estimado para hipoxemia em portadores de DVP foi de pelo menos 30% em dois anos; A identificação precoce do aparecimento da hipoxemia pode levar a um melhor entendimento da história natural da SHP e ser útil para a otimização da indicação do transplante de fígado e obtenção de melhores resultados.

The primary purpose of this doctoral dissertation was to investigate the effect of body temperature responses at physiologically relevant sites during an incremental exercise test on the phenomenon of exercise-induced hypoxemia (EIH). This phenomenon has been considered as an important limitation to physical performance with a prevalence of ~50 % in trained male athletes, but described in both sexes, across the range of both age and physical fitness in more recent literature. Previously this phenomenon has been described as a decrement in both arterial oxygen partial pressure (PaO₂) and oxy-haemoglobin saturation (SaO₂or SpO₂) with, particularly important for PaO₂, a lack of or inappropriate correction made for the change in body temperature during intense exercise. The initial study of this thesis determined the thermal response within the body at physiologically relevant sites measured simultaneously during an incremental exercise test. The results demonstrated the inadequacy of rectal temperature as an indicator of the acute temperature changes occurring during an incremental exercise test due to its slow response rate and relative thermal inertia. Radial arterial blood and oesophageal temperatures were shown to behave almost identically during the exercise test, albeit with an offset of approximately 1.3ºC, and were considered much more appropriate and relevant indicators of thermal changes during exercise. As an extension of the initial work active muscle temperature (vastus lateralis) was measured during the exercise test, demonstrating a significantly lower resting temperature than the oft-reported “core” temperatures (rectal and oesophageal) as well as a significantly greater increase in temperature in comparison to all other measurement sites. Overall, the results of this first study indicated that the physiologically relevant temperatures measured at the oesophageal and muscle sites differed markedly to the outdated rectal temperature measurement site and should be used as measures of thermal response when evaluating oxygen loading (oesophageal) or unloading (active muscle). Utilising the definition of EIH as a decrease in PaO₂ of ≥ 10 mmHg, the effect of temperature correcting PaO₂ was evaluated in the second study. Arterial blood gases measured simultaneously to the temperature measurements during the incremental exercise test were adjusted for the temperature changes at each site (every 1ºC increase in temperature will increase a PaO₂ value by ~5 mmHg). Whilst uncorrected PaO₂ values indicated an almost 100% prevalence of EIH in this group, oesophageal temperature corrected PaO₂ values decreased this prevalence to ~50% while muscle temperature corrections resolved all cases of EIH and demonstrated an HYPEROXAEMIA (i.e. the reverse of the well-established phenomenon) in the majority of subjects. Further investigation of arterial oxygen content during the exercise test indicates that there is no disruption in the delivery of oxygen to the active muscles and therefore any performance decrement should be attributed to another mechanism. Whilst the phenomenon of EIH is determined by the definition applied and the use of temperature corrections in the case of PaO₂, its reproducibility in a test-retest situation had not previously been determined. Utilising a subset of previously tested subjects, the reproducibility of both temperature and PaO₂ were determined with results indicating that the blood gas response was highly reproducible, especially the minimum PaO₂ value noted during each exercise test. However, comparing a more statistically relevant definition of a change in PaO₂ of ± 2 standard deviations from the mean resting PaO₂ to the previous delimiter of 10 mmHg indicated a lesser reproducibility of the prevalence of EIH. In summary, this thesis exposes the inadequacies of previous research into EIH with regard to the expected reproducibility of the phenomenon and the need to correctly adjust PaO₂ values for exercise-induce hyperthermia as well as demonstrating the difference in thermal responses to acute exercise in physiologically significant areas of the body. Furthermore, previously described correlations between the change in PaO₂ and VO₂ max were not evident in the subjects tested within this thesis, nor was there any indication of a diffusion limitation based on reduced pulmonary capillary transit time (by association with VO₂ max) or pulmonary oedema (rebuked by a rapid return of PaO₂ to above resting levels following exercise cessation). / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1320633 / Thesis (Ph.D.) -- University of Adelaide, School of Medicine, 2008

The primary purpose of this doctoral dissertation was to investigate the effect of body temperature responses at physiologically relevant sites during an incremental exercise test on the phenomenon of exercise-induced hypoxemia (EIH). This phenomenon has been considered as an important limitation to physical performance with a prevalence of ~50 % in trained male athletes, but described in both sexes, across the range of both age and physical fitness in more recent literature. Previously this phenomenon has been described as a decrement in both arterial oxygen partial pressure (PaO₂) and oxy-haemoglobin saturation (SaO₂or SpO₂) with, particularly important for PaO₂, a lack of or inappropriate correction made for the change in body temperature during intense exercise. The initial study of this thesis determined the thermal response within the body at physiologically relevant sites measured simultaneously during an incremental exercise test. The results demonstrated the inadequacy of rectal temperature as an indicator of the acute temperature changes occurring during an incremental exercise test due to its slow response rate and relative thermal inertia. Radial arterial blood and oesophageal temperatures were shown to behave almost identically during the exercise test, albeit with an offset of approximately 1.3ºC, and were considered much more appropriate and relevant indicators of thermal changes during exercise. As an extension of the initial work active muscle temperature (vastus lateralis) was measured during the exercise test, demonstrating a significantly lower resting temperature than the oft-reported “core” temperatures (rectal and oesophageal) as well as a significantly greater increase in temperature in comparison to all other measurement sites. Overall, the results of this first study indicated that the physiologically relevant temperatures measured at the oesophageal and muscle sites differed markedly to the outdated rectal temperature measurement site and should be used as measures of thermal response when evaluating oxygen loading (oesophageal) or unloading (active muscle). Utilising the definition of EIH as a decrease in PaO₂ of ≥ 10 mmHg, the effect of temperature correcting PaO₂ was evaluated in the second study. Arterial blood gases measured simultaneously to the temperature measurements during the incremental exercise test were adjusted for the temperature changes at each site (every 1ºC increase in temperature will increase a PaO₂ value by ~5 mmHg). Whilst uncorrected PaO₂ values indicated an almost 100% prevalence of EIH in this group, oesophageal temperature corrected PaO₂ values decreased this prevalence to ~50% while muscle temperature corrections resolved all cases of EIH and demonstrated an HYPEROXAEMIA (i.e. the reverse of the well-established phenomenon) in the majority of subjects. Further investigation of arterial oxygen content during the exercise test indicates that there is no disruption in the delivery of oxygen to the active muscles and therefore any performance decrement should be attributed to another mechanism. Whilst the phenomenon of EIH is determined by the definition applied and the use of temperature corrections in the case of PaO₂, its reproducibility in a test-retest situation had not previously been determined. Utilising a subset of previously tested subjects, the reproducibility of both temperature and PaO₂ were determined with results indicating that the blood gas response was highly reproducible, especially the minimum PaO₂ value noted during each exercise test. However, comparing a more statistically relevant definition of a change in PaO₂ of ± 2 standard deviations from the mean resting PaO₂ to the previous delimiter of 10 mmHg indicated a lesser reproducibility of the prevalence of EIH. In summary, this thesis exposes the inadequacies of previous research into EIH with regard to the expected reproducibility of the phenomenon and the need to correctly adjust PaO₂ values for exercise-induce hyperthermia as well as demonstrating the difference in thermal responses to acute exercise in physiologically significant areas of the body. Furthermore, previously described correlations between the change in PaO₂ and VO₂ max were not evident in the subjects tested within this thesis, nor was there any indication of a diffusion limitation based on reduced pulmonary capillary transit time (by association with VO₂ max) or pulmonary oedema (rebuked by a rapid return of PaO₂ to above resting levels following exercise cessation). / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1320633 / Thesis (Ph.D.) -- University of Adelaide, School of Medicine, 2008

No description available.

Thèse numérisée par la Division de la gestion de documents et des archives de l'Université de Montréal

L’adaptation des principes ERAS à l’anesthésie du lapin pourrait améliorer leur taux de mortalité périopératoire élevé. Le développement d’un protocole IM réversible pourrait raccourcir le réveil et diminuer les complications. Les objectifs de ce mémoire sont 1) d’investiguer la relation entre l’administration d’oxygène et la ventilation et 2) de définir les paramètres PK-PD du midazolam IV midazolam et son antagoniste flumazénil chez le lapin. Dans une étude prospective, randomisée, à l’aveugle, 25 lapins de Nouvelle-Zélande (4 mâles, 21 femelles ; 3,1–5,9 kg ; 1 an) ont été anesthésiés avec l’alfaxalone (4 mg/kg), dexmédétomidine (0,1 mg/kg) et midazolam (0,2 mg/kg) IM et randomisés à attendre 5 (n = 8) ou 10 (n = 17) minutes entre l’injection anesthésique et l’administration d’oxygène (100%) ou air médical (masque,1 L/minute). Avant (PREoxy/air5/10) et 2 minutes après l’oxygène ou l’air médical (POSToxy/air5/10), la fréquence respiratoire (fR), pH, PaCO2, PaO2 ont été investigués. L’hypoxémie (PaO2 < 88 mmHg) était présente à tous les temps PRE : PREoxy5 [71 (61–81) mmHg] ; PREoxy10 [58 (36–80) mmHg] et PREair10 [48 (32–64) mmHg]. L’hypoxémie a persisté avec l’air médical : POSTair10 [49 (33–66) mmHg]. L’administration d’oxygène a corrigé l’hypoxémie, mais était associée avec une diminution de fR (> 70% ; p = 0,016, deux groupes) et de l’hypercapnie (p = 0,016, deux groupes). fR restait inchangé avec l’air médical (p = 0,5). PaCO2 était plus élevé avec l’oxygène que l’air (p < 0,001). L’administration d’oxygène précoce a résolu l’hypoxémie reliée à l’anesthésie, mais a empiré l’hypoventilation démontrant que la stimulation respiratoire hypoxique est un facteur important contribuant à la ventilation lorsque ce protocole anesthésique est utilisé. Dans une étude prospective, randomisée, à l’aveugle et croisé, 15 lapins de Nouvelle-Zélande (7 mâles, 8 femelles; 2,73 – 4,65 kg ; 1 an) ont reçu midazolam IV (1,2 mg/kg) à T0 suivi de flumazénil IV (FLU ; 0,05 mg/kg) ou saline (SAL ; même volume) pour renverser la perte du réflexe de redressement (LORR). Le traitement (FLU/SAL) était injecté 30 secondes après LORR. L’échantillonnage sanguin artériel était analysé avec la technique de chromatographie liquide/spectrométrie de masse. Le temps pour le retour du réflexe de redressement (ReRR) était analysé. Demi-vie, clairance plasmatique and volume de distribution du FLU étaient 26,3 min [95%CI : 23,3–29,3], 18,74 mL/min/kg [16,47–21,00] et 0,63 L/kg [0,55–0,71], respectivement. ReRR était 25 fois plus rapide pour FLU (23 [8–44] secondes) versus SAL (576 [130–1141] secondes ; p<0.001, 95%CI [425–914 secondes]). Le retour de la sédation (LORR) était présent dans les deux groupes (4/13 FLU ; 7/13 SAL) à 1540 [858–2328] secondes. Le flumazénil a rapidement antagonisé la sédation du midazolam. Cependant, le potentiel de resédation après l’utilisation du flumazénil nécessite une surveillance accrue durant la période de réveil. / Adapting ERAS guideline principles to rabbit anesthesia could improve their risk of perioperative mortality which remains elevated. The development of a reversible IM protocol could hasten recovery and decrease complications. The objectives of this thesis were 1) to investigate the relationship between oxygen administration and ventilation, 2) to define PK-PD parameters of IV midazolam and its antagonist flumazenil in rabbits. In a prospective, randomized, blinded study, 25 New Zealand White rabbits (4 males, 21 females; 3.1–5.9 kg; 1 year old) were anesthetized with IM alfaxalone (4 mg/kg), dexmedetomidine (0.1 mg/kg) and midazolam (0.2 mg/kg) and randomized to a 5 (n = 8) or 10 (n = 17) minutes waiting period between drug injection and oxygen (100%) or medical air administration (facemask, 1 L/minute). Immediately before (PREoxy/air5/10) and 2 minutes after oxygen or medical air (POSToxy/air5/10), respiratory rate (fR), pH, PaCO2, PaO2 were investigated. Hypoxemia (PaO2 < 88 mmHg) was observed at all PRE times. PREoxy5 [71 (61–81) mmHg]; PREoxy10 [58 (36–80) mmHg] and PREair10 [48 (32–64) mmHg]. Hypoxemia persisted when breathing air: POSTair10 [49 (33–66) mmHg]. Oxygen administration corrected hypoxemia but was associated with decreased fR (> 70%; p = 0.016, both groups) and hypercapnia (p = 0.016, both groups). fR was unchanged breathing air (p = 0.5). PaCO2 was higher when breathing oxygen than air (p < 0.001). Early oxygen administration resolved anesthesia-induced hypoxemia, but worsened hypoventilation indicating that hypoxic respiratory drive is an important contributor to ventilation using the studied drug combination. In a prospective, randomized, blinded, crossover study, 15 New Zealand White rabbits (7 males, 8 females; 2.73 – 4.65 kg, 1 year old) received IV midazolam (1.2 mg/kg) followed by IV flumazenil (FLU; 0.05 mg/kg) or saline control (SAL; equal volume) to reverse loss of righting reflex (LORR). Midazolam was injected (T0). Treatment (FLU/SAL) injected 30 seconds after LORR. Arterial blood samples were collected and analyzed using liquid chromatography/mass spectrometry. Time to return of righting reflex (ReRR) compared between groups. FLU terminal half-life, plasma clearance and volume of distribution were 26.3 min [95%CI: 23.3–29.3], 18.74 mL/min/kg [16.47–21.00] and 0.63 L/kg [0.55–0.71], respectively. ReRR was 25 times faster in FLU (23 [8–44] seconds) versus SAL (576 [130–1141] seconds; p<0.001, 95%CI [425–914 seconds]). Return of sedation (LORR) occurred in both groups (4/13 in FLU; 7/13 in SAL) at 1540 [858–2328] seconds. Flumazenil quickly and reliably reversed sedation from midazolam injection. However, the potential resedation after flumazenil administration warrants careful monitoring in the recovery period.

L’insuffisance respiratoire hypoxémique aigüe (IRHA) est une des causes les plus fréquentes d’admission aux soins intensifs pédiatriques. Elle est liée à plusieurs mécanismes dont le plus grave est l’œdème pulmonaire lésionnel conduisant au syndrome de détresse respiratoire aigüe (SDRA) pédiatrique qui représente 5-10 % des patients admis aux soins intensifs. Actuellement, les recommandations internationales de prise en charge de l’IRHA et du SDRA sont sous-appliquées du fait d’un défaut de diagnostic ou d’un diagnostic tardif. Ceci est probablement en partie responsable d’une ventilation mécanique prolongée dans le SDRA pédiatrique. Afin d’améliorer les critères d’évaluation de l’IRHA chez les enfants et éventuellement leur devenir, les 3 objectifs de cette thèse sont d’améliorer le diagnostic précoce d’IRHA chez l’enfant, informatiser un score de gravité de défaillance d’organes (score PELOD-2) utilisable comme critère de jugement principal en recherche en remplacement de la mortalité qui est faible dans cette population et prédire la ventilation prolongée chez la population la plus fragile, les nouveau-nés. Pour réaliser ces objectifs, nous avons : 1) optimisé une base de données haute résolution temporelle unique au monde, 2) validé un indice continu d’oxygénation utilisable en temps réel et robuste à toutes les valeurs de saturations pulsées en oxygène, 3) validé une version informatisée du score PELOD-2 utilisable comme critère de jugement principal en recherche, 4) développé un modèle prédictif d’IRHA persistante dû à l’influenza et 5) proposé une définition de la ventilation prolongée en pédiatrie applicable quel que soit l’âge et le terme de l’enfant et 6) étudié le devenir des nouveau-nés ayant une ventilation prolongée et proposé un modèle prédictif du sous-groupe le plus grave. Les méthodes utilisées à travers ces différentes études ont associé la science des données massives pour le regroupement, la synchronisation et la normalisation des données continues. Nous avons également utilisé les statistiques descriptives, la régression linéaire et logistique, les forêts aléatoires et leurs dérivés, l’apprentissage profond et l’optimisation empirique d’équations mathématiques pour développer et valider des modèles prédictifs. L’interprétation des modèles et l’importance de chaque variable ont été quantifiées soit par l’analyse de leurs coefficients (statistiques conventionnelles) soit par permutation ou masquage des variables dans le cas de modèles d’apprentissage automatique. En conclusion, l’ensemble de ce travail, soit la reconnaissance et la pronostication automatique de l’IRHA chez l’enfant vont me permettre de développer, de valider et d’implanter un système d’aide à la décision en temps réel pour l’IRHA en pédiatrie. / Acute hypoxemic respiratory failure (AHRF) is one of the most frequent causes of admission to pediatric intensive care units. It is related to several mechanisms, the most serious of which is lesional pulmonary edema leading to pediatric acute respiratory distress syndrome (ARDS), which accounts for 5–10% of patients admitted to intensive care. Currently, international guidelines for the management of ARDS are under-implemented due to failure to diagnose or late diagnosis. This is probably partly responsible for prolonged mechanical ventilation in pediatric ARDS. In order to improve the criteria for assessing AHRF in children and possibly their outcome, we aimed to improve the early diagnosis of ARDS in children, to automate an organ failure severity score (PELOD-2 score) that can be used as a primary endpoint in research to replace mortality, which is low in this population, and to predict prolonged ventilation in the most fragile population, neonates. To achieve these objectives, we have: 1) optimized a unique high temporal resolution database, 2) validated a continuous oxygenation index usable in real time and robust to all values of pulsed oxygen saturation, 3) validated a computerized version of the PELOD-2 score usable as a primary outcome in research, 4) developed a predictive model of persistent AHRF due to influenza and 5) proposed a definition of prolonged ventilation in pediatrics applicable regardless of the age and term of the child and 6) studied the outcome of newborns with prolonged ventilation and proposed a predictive model of the most severe subgroup. The methods used across these different studies combined big data science for clustering, synchronization, and normalization of continuous data. We also used descriptive statistics, linear and logistic regression, random forests and their derivatives, deep learning, and empirical optimization of mathematical equations to develop and validate predictive models. The interpretation of the models and the importance of each variable were quantified either by analyzing their coefficients (conventional statistics) or by permuting or masking the variables in the case of machine learning models. In conclusion, all this work, i.e. the recognition and automatic prognosis of AHRF in children will allow me to develop, validate and implement a real-time decision support system for AHRF in pediatrics.